Literature DB >> 25722460

Is there a role for conventional MRI and MR diffusion-weighted imaging for distinction of skull base chordoma and chondrosarcoma?

Uta Müller1, Rahel A Kubik-Huch2, Carmen Ares3, Eugen B Hug4, Roland Löw2, Antonios Valavanis5, Frank J Ahlhelm2.   

Abstract

BACKGROUND: Chordoma and chondrosarcoma are locally invasive skull base tumors with similar clinical symptoms and anatomic imaging features as reported in the literature.
PURPOSE: To determine differentiation of chordoma and chondrosarcoma of the skull base with conventional magnetic resonance imaging (cMRI) and diffusion-weighted MR imaging (DWI) in comparison to histopathological diagnosis.
MATERIAL AND METHODS: This retrospective study comprised 96 (chordoma, n = 64; chondrosarcoma, n = 32) patients with skull base tumors referred to the Paul Scherrer Institute (PSI) for proton therapy. cMRI signal intensities of all tumors were investigated. In addition, median apparent diffusion coefficient (ADC) values were measured in a subgroup of 19 patients (chordoma, n = 11; chondrosarcoma, n = 8).
RESULTS: The majority 81.2% (26/32) of chondrosarcomas displayed an off-midline growth pattern, 18.8% (6/32) showed clival invasion, 18.8% (6/32) were located more centrally. Only 4.7% (3/64) of chordomas revealed a lateral clival origin. Using cMRI no significant differences in MR signal intensities were observed in contrast to significantly different ADC values (subgroup of 19/96 patients examined by DWI), with the highest mean value of 2017.2 × 10(-6 )mm(2)/s (SD, 139.9( )mm(2)/s) for chondrosarcoma and significantly lower value of 1263.5 × 10(-6 )mm(2)/s (SD, 100.2 × 10(-6 )mm(2)/s) for chordoma (P = 0.001/median test).
CONCLUSION: An off-midline growth pattern can differentiate chondrosarcoma from chordoma on cMRI in a majority of patients. Additional DWI is a promising tool for the differentiation of these skull base tumors. © The Foundation Acta Radiologica 2015.

Entities:  

Keywords:  ADC map; Magnetic resonance imaging (MRI); chondrosarcoma; chordoma; diffusion-weighted MRI (DWI); skull base tumor

Mesh:

Year:  2015        PMID: 25722460     DOI: 10.1177/0284185115574156

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  16 in total

1.  The Added Value of Diffusion Magnetic Resonance Imaging in the Diagnosis and Posttreatment Evaluation of Skull Base Chordomas.

Authors:  Ezgi Guler; Burce Ozgen; Melike Mut; Figen Soylemezoglu; Kader Karli Oguz
Journal:  J Neurol Surg B Skull Base       Date:  2017-01-23

2.  Revisitation of imaging features of skull base chondrosarcoma in comparison to chordoma.

Authors:  Hirotaka Hasegawa; Masahiro Shin; Ryoko Niwa; Satoshi Koizumi; Shoko Yoshimoto; Naoyuki Shono; Yuki Shinya; Hirokazu Takami; Shota Tanaka; Motoyuki Umekawa; Shiori Amemiya; Taichi Kin; Nobuhito Saito
Journal:  J Neurooncol       Date:  2022-07-26       Impact factor: 4.506

3.  MRI-Based Radiomics Differentiates Skull Base Chordoma and Chondrosarcoma: A Preliminary Study.

Authors:  Erika Yamazawa; Satoshi Takahashi; Masahiro Shin; Shota Tanaka; Wataru Takahashi; Takahiro Nakamoto; Yuichi Suzuki; Hirokazu Takami; Nobuhito Saito
Journal:  Cancers (Basel)       Date:  2022-07-03       Impact factor: 6.575

4.  A Cystic Clival Chordoma with CT and MRI Unconventional Appearances.

Authors:  Pamela Guadalupi; Marco Gessi; Luca Massimi; Massimo Caldarelli; Simona Gaudino
Journal:  Indian J Radiol Imaging       Date:  2022-02-28

Review 5.  [Tumors of the sellar region].

Authors:  J M Lieb; F J Ahlhelm
Journal:  Radiologe       Date:  2017-09       Impact factor: 0.635

6.  Malignant bone tumors (other than Ewing's): clinical practice guidelines for diagnosis, treatment and follow-up by Spanish Group for Research on Sarcomas (GEIS).

Authors:  Andrés Redondo; Silvia Bagué; Daniel Bernabeu; Eduardo Ortiz-Cruz; Claudia Valverde; Rosa Alvarez; Javier Martinez-Trufero; Jose A Lopez-Martin; Raquel Correa; Josefina Cruz; Antonio Lopez-Pousa; Aurelio Santos; Xavier García Del Muro; Javier Martin-Broto
Journal:  Cancer Chemother Pharmacol       Date:  2017-10-16       Impact factor: 3.333

Review 7.  State-of-the-Art Imaging in Human Chordoma of the Skull Base.

Authors:  Rene G C Santegoeds; Yasin Temel; Jan C Beckervordersandforth; Jacobus J Van Overbeeke; Christianne M Hoeberigs
Journal:  Curr Radiol Rep       Date:  2018-04-03

Review 8.  Skull base chordomas review of current treatment paradigms.

Authors:  Dan Yaniv; Ethan Soudry; Yulia Strenov; Marc A Cohen; Aviram Mizrachi
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2020-04-18

Review 9.  Chondrosarcoma-from Molecular Pathology to Novel Therapies.

Authors:  Agnieszka E Zając; Sylwia Kopeć; Bartłomiej Szostakowski; Mateusz J Spałek; Michał Fiedorowicz; Elżbieta Bylina; Paulina Filipowicz; Anna Szumera-Ciećkiewicz; Andrzej Tysarowski; Anna M Czarnecka; Piotr Rutkowski
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

10.  Apparent diffusion coefficient and arterial spin labeling perfusion of conventional chondrosarcoma in the parafalcine region: a case report.

Authors:  Daigo Kojima; Takaaki Beppu; Hiroaki Saura; Yuichi Sato; Shunrou Fujiwara; Kuniaki Ogasawara
Journal:  Radiol Case Rep       Date:  2017-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.